TME Pharma AG
15 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer (NCT04901741) | TME Pharma AG | 2026-01-01 |
| Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients (NCT04121455) | TME Pharma AG | 2019-09-12 |
Track TME Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.